IMPORTANT: You have entered information relating to pharmaceutical products approved for sale by prescription. Under Chilean law, the promotion and advertising of these products is restricted to professionals who prescribe and dispense. The information contained in this page is specialized technical and scientific information, and is intended exclusively for use by health professionals trained in their proper interpretation. Laboratorios Saval S.A. is not responsible for the consequences that the information published here can generate in the visitor or health care professional, through it, of others. The consequences of using this information without consulting a professional pose grave risks to life and health.
IMPORTANT: You have entered information relating to pharmaceutical products approved for sale by prescription. Under Chilean law, the promotion and advertising of these products is restricted to professionals who prescribe and dispense. The information contained in this page is specialized technical and scientific information, and is intended exclusively for use by health professionals trained in their proper interpretation. Laboratorios Saval S.A. is not responsible for the consequences that the information published here can generate in the visitor or health care professional, through it, of others. The consequences of using this information without consulting a professional pose grave risks to life and health.
MOXOF
Moxifloxacin
Composition
Each 100 ml of ophthalmic solution contains: Moxifloxacin (as hydrochloride) 0,5 g Excipients q.s.
Presentations
Sealed drop-dispenser bottle with 5 mL of sterile ophthalmic solution
Indications
Moxof is indicated for the treatment of bacterial conjunctivitis caused by susceptible microorganism strains.